Evidence map›Paper›PMID 33496885›Full record

ArticleScience and engineering ethics2021

Three Risks That Caution Against a Premature Implementation of Artificial Moral Agents for Practical and Economical Use.

Christian Herzog

Abstract read
In one paragraph

Article in Science and engineering ethics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Christian HerzogEthical Innovation Hub, Institute for Electrical Engineering in Medicine, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. christian.herzog@uni-luebeck.de.ORCID 0000-0003-2513-2563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present article, I will advocate caution against developing artificial moral agents (AMAs) based on the notion that the utilization of preliminary forms of AMAs will potentially negatively feed back on the human social system and on human moral thought itself and its value-e.g., by reinforcing social inequalities, diminishing the breadth of employed ethical arguments and the value of character. While scientific investigations into AMAs pose no direct significant threat, I will argue against their premature utilization for practical and economical use. I will base my arguments on two thought experiments. The first thought experiment deals with the potential to generate a replica of an individual's moral stances with the purpose to increase, what I term, 'moral efficiency'. Hence, as a first risk, an unregulated utilization of premature AMAs in a neoliberal capitalist system is likely to disadvantage those who cannot afford 'moral replicas' and further reinforce social inequalities. The second thought experiment deals with the idea of a 'moral calculator'. As a second risk, I will argue that, even as a device equally accessible to all and aimed at augmenting human moral deliberation, 'moral calculators' as preliminary forms of AMAs are likely to diminish the breadth and depth of concepts employed in moral arguments. Again, I base this claim on the idea that the current most dominant economic system rewards increases in productivity. However, increases in efficiency will mostly stem from relying on the outputs of 'moral calculators' without further scrutiny. Premature AMAs will cover only a limited scope of moral argumentation and, hence, over-reliance on them will narrow human moral thought. In addition and as the third risk, I will argue that an increased disregard of the interior of a moral agent may ensue-a trend that can already be observed in the literature.

Indexed as

MoralsHumansAI ethicsArtificial intelligenceArtificial moral agentsMachine ethicsRobot ethics

Identifiers

PMID33496885
PMCPMC7838071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.